HD5 TFA is an innate immune effector peptide and SARS-CoV Inhibitor. HD5 TFA binds to the ligand-binding domain of angiotensin-converting enzyme-2 (ACE2) via multiple hydrogen bonds to competitively block the receptor, shielding it from viral recognition. HD5 TFA can be used for the research of COVID-19, HPV16 infection, epithelial ovarian cancer, small-cell lung cancer, and colon cancer[1][2][3].
Molecular Weight:
3582.13 (free base)
Purity:
95.30
Formula:
C144H238N50O45S6xC2HF3O2
Target:
Angiotensin-converting Enzyme (ACE),SARS-CoV
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
